La traduction est en cours. L’article original est affiché.
Company Logo Dublin, Nov. 05, 2026 (GLOBE NEWSWIRE) -- "Pharmacovigilance and Drug Safety Software - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global pharmacovigilance and drug safety software market was valued at US$227.4 million in 2025 and is projected to reach US$336.5 million by 2032, expanding at a compound annual growth rate (CAGR) of 5.8%. Market growth is supported by increasingly stringent regulatory requirements, rising adverse event data volumes, greater global pharmaceutical consumption, and demand for real-time drug safety monitoring and advanced analytics.
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.